NDC 80425-0117-02 - Orphenadrine Citrate ER
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0117
- Requested NDC
- 80425-0117-02
- Package NDCs from labels
- 80425-0117-1, 80425-0117-2, 80425-0117-02
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Orphenadrine Citrate ER - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0117-1 | Orphenadrine CitrateER | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 6 | |
| 80425-0117-2 | Orphenadrine CitrateER | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0117 | ORPHENADRINE CITRATE ER (ORPHENADRINE CITRATE) TABLET, EXTENDED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20250101_b5a6846a-ebb3-1fdd-e053-2a95a90a4130.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0117-1 | EA - Each | 80425-0117 | 6875530b-65eb-4b30-8141-3c4a785f548a | 1 | 2023-06-06 |
| 80425-0117-2 | EA - Each | 80425-0117 | e8276d9e-8686-4581-a97e-dd1e868f4c5c | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | REMEDYREPACK INC. | 7905e80f-b60b-48e8-8e63-a3e50211bfe4 | 2026-08-10 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Preferred Pharmaceuticals, Inc. | 8ca9438d-320f-4499-aee7-6b8ca7cccc65 | 2026-08-07 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | St. Mary's Medical Park Pharmacy | 59000b66-166e-75d2-e053-2a91aa0af3c0 | 2026-06-26 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Bryant Ranch Prepack | 1b4e379e-8051-421f-a0f4-ad9e6fb9476a | 2026-02-26 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | A-S Medication Solutions | 80ef7fb4-7c50-4d25-915e-f9d4a2ccd199 | 2026-01-20 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Norgesic | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Galt Pharmaceuticals, LLC | be2761bc-e537-4039-846a-2ffa3d8b2afc | 2026-01-08 | Warnings, Adverse reactions | X0A40N8I4S |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | PD-Rx Pharmaceuticals, Inc. | 87d78229-f022-4b42-a03c-4e6a985c714f | 2026-01-07 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Northwind Health Company, LLC | 106be130-b4f8-5ca1-e063-6294a90a1590 | 2026-01-01 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Norgesic Forte | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Poly Pharmaceuticals, Inc. | 85a3b808-b476-f2f0-e053-2a91aa0af21f | 2025-12-30 | Warnings, Adverse reactions | X0A40N8I4S |
| Orphenadrine Citrate, Aspirin and Caffeine | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Atland Pharmaceuticals, LLC | 7776aae6-3cbd-4aed-9aac-4bed80339e27 | 2025-10-17 | Warnings, Adverse reactions | X0A40N8I4S |
| ORPHENGESIC FORTE | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Galt Pharmaceuticals, LLC | 5bc485db-9d96-4291-aaa3-2a96ebf3098a | 2025-10-16 | Warnings, Adverse reactions | X0A40N8I4S |
| Orphenadrine Citrate, Aspirin and Caffeine | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Atland Pharmaceuticals, LLC | 61ca2af1-081c-411c-90ce-ec6d9e3157b2 | 2025-10-16 | Warnings, Adverse reactions | X0A40N8I4S |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Lupin Pharmaceuticals, Inc. | 7b76c8a7-dd0c-481c-8299-26dfd38ce066 | 2025-09-10 | Warnings, Adverse reactions | ANDA040284 43386-480 994521 e80ecc89-bd45-4796-850b-c379a79ac7ab 7b76c8a7-dd0c-481c-8299-26dfd38ce066 X0A40N8I4S |
| Orphenadrine Citrate ER | ORPHENADRINE CITRATE | Advanced Rx Pharmacy of Tennessee, LLC | b5a6846a-ebb3-1fdd-e053-2a95a90a4130 | 2024-12-31 | Warnings, Adverse reactions | ANDA040284 80425-0117-2 80425-0117-1 80425-0117 80425011702 994521 2a996b2b-b5dc-65e7-e063-6394a90adeed b5a6846a-ebb3-1fdd-e053-2a95a90a4130 X0A40N8I4S |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Advanced Rx Pharmacy of Tennessee, LLC | fc63d413-39bd-409d-e053-6294a90a1463 | 2024-12-31 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Lake Erie Medical DBA Quality Care Products LLC | 233915f1-7d58-4b4c-a2bb-e73179d61d07 | 2024-12-16 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Bryant Ranch Prepack | 8408d24e-3948-548d-bb12-b1edf0c05e12 | 2024-08-27 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | NuCare Pharmaceuticals, Inc. | 3eb1b1cc-ed7a-6f0f-e054-00144ff88e88 | 2024-08-13 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine citrate | ORPHENADRINE CITRATE | Hikma Pharmaceuticals USA Inc. | ed406e8a-ec00-4711-ae2b-3c5af4f15438 | 2024-08-08 | Warnings, Adverse reactions | X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | RedPharm Drug | 1cff761d-e594-a9e6-e063-6394a90a1fd5 | 2024-07-11 | Warnings, Adverse reactions | 994521 X0A40N8I4S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.